Terms: = Bone cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Treatment
91 results:
1. Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Katodritou E; Kastritis E; Dalampira D; Delimpasi S; Spanoudakis E; Labropoulou V; Ntanasis-Stathopoulos I; Gkioka AI; Giannakoulas N; Kanellias N; Papadopoulou T; Sevastoudi A; Michalis E; Papathanasiou M; Kotsopoulou M; Sioni A; Triantafyllou T; Daiou A; Papadatou M; Kyrtsonis MC; Pouli A; Kostopoulos I; Verrou E; Dimopoulos MA; Terpos E
Am J Hematol; 2023 May; 98(5):730-738. PubMed ID: 36869876
[TBL] [Abstract] [Full Text] [Related]
2. Receptor Tyrosine Kinase Inhibitors for the treatment of Recurrent and Unresectable bone Sarcomas.
Albarrán V; Villamayor ML; Chamorro J; Rosero DI; Pozas J; San Román M; Calvo JC; Pérez de Aguado P; Moreno J; Guerrero P; González C; García de Quevedo C; Álvarez-Ballesteros P; Vaz MÁ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430263
[TBL] [Abstract] [Full Text] [Related]
3. [Myeloid neoplasms associated with rearrangement of pdgfrb: A rare and tricky disease].
Bontoux C; Badaoui B; Abermil N; Tarfi S; Guermouche H; Dubois S; Roy L; Xuan JV; Quang VT; Wang L; Favre L; Poullot E; Michel M; Sloma I; Crickx E; Pécriaux A
Ann Pathol; 2022 Nov; 42(6):481-487. PubMed ID: 36050197
[TBL] [Abstract] [Full Text] [Related]
4. Her2/EGFR-pdgfr pathway aberrations associated with tamoxifen response in metastatic breast cancer patients.
Malash I; Mansour O; Gaafar R; Shaarawy S; Abdellateif MS; Ahmed OS; Zekri AN; Bahnassy A
J Egypt Natl Canc Inst; 2022 Jul; 34(1):31. PubMed ID: 35871690
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Podoplanin for the treatment of Osteosarcoma.
Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (pdgfr) Inhibitors for the treatment of Osteosarcoma.
Chen X; Liu L; Liu P; Chen Y; Lin D; Yan H; Yan Q; Wang Y; Qiu Y; Fang B; Huang H; Qian J; Zhao Y; Du Z; Zhang Q; Li X; Zheng X; Liu Z
J Med Chem; 2022 Apr; 65(7):5374-5391. PubMed ID: 35239349
[TBL] [Abstract] [Full Text] [Related]
7. [Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of pdgfrb due to t (5;14)(q33;q22)].
Fujii T; Ohno N; Matsui T; Kitahara S; Kobayashi S; Sahara N; Sakamoto N; Matsunaga T
Rinsho Ketsueki; 2021; 62(11):1635-1638. PubMed ID: 34866089
[TBL] [Abstract] [Full Text] [Related]
8. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.
Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
[TBL] [Abstract] [Full Text] [Related]
9. Computed tomography guided radiofrequency ablation of osteoid osteoma in children: a single center's experience.
Filippiadis D; Stefanou D; Mazioti A; Foti L; Tsochatzis A; Kelekis N; Kelekis A
Skeletal Radiol; 2022 Apr; 51(4):855-861. PubMed ID: 34515814
[TBL] [Abstract] [Full Text] [Related]
10. Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages.
Smith BD; Kaufman MD; Wise SC; Ahn YM; Caldwell TM; Leary CB; Lu WP; Tan G; Vogeti L; Vogeti S; Wilky BA; Davis LE; Sharma M; Ruiz-Soto R; Flynn DL
Mol Cancer Ther; 2021 Nov; 20(11):2098-2109. PubMed ID: 34433663
[TBL] [Abstract] [Full Text] [Related]
11. Myeloid tumors accompanying systemic mastocytosis, basophilia, and abnormal platelet-derived growth factor receptor β: A case report.
Li Y; Jing Y; Wan H; Liu D
Medicine (Baltimore); 2021 Feb; 100(8):e24707. PubMed ID: 33663081
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a Novel CSNK2A1-pdgfrb Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
[TBL] [Abstract] [Full Text] [Related]
13. Down-regulation of pdgfrβ suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition.
Xing S; Wang C; Tang H; Guo J; Liu X; Yi F; Liu G; Wu X
FEBS Open Bio; 2020 Sep; 10(9):1748-1757. PubMed ID: 32580247
[TBL] [Abstract] [Full Text] [Related]
14. Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium.
Harrison DJ; Gill JD; Roth ME; Zhang W; Teicher B; Erickson S; Gatto G; Kurmasheva RT; Houghton PJ; Smith MA; Kolb EA; Gorlick R
Pediatr Blood Cancer; 2020 Jun; 67(6):e28222. PubMed ID: 32207565
[TBL] [Abstract] [Full Text] [Related]
15. Gene expression profile and bioinformatics analysis revealed key molecular characteristics of chordoma-before and after TNF- a treatment.
Xu G; Liu C; Liang T; Zhang Z; Jiang J; Chen J; Xue J; Zeng H; Lu Z; Zhan X
Medicine (Baltimore); 2020 Jan; 99(3):e18790. PubMed ID: 32011476
[TBL] [Abstract] [Full Text] [Related]
16. Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors.
Doi T; Matsubara N; Kawai A; Naka N; Takahashi S; Uemura H; Yamamoto N
Invest New Drugs; 2020 Aug; 38(4):1175-1185. PubMed ID: 31820255
[TBL] [Abstract] [Full Text] [Related]
17. An update on current and future treatment options for chondrosarcoma.
MacDonald IJ; Lin CY; Kuo SJ; Su CM; Tang CH
Expert Rev Anticancer Ther; 2019 Sep; 19(9):773-786. PubMed ID: 31462102
[No Abstract] [Full Text] [Related]
18. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract] [Full Text] [Related]
19. Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51.
Kaplan AR; Gueble SE; Liu Y; Oeck S; Kim H; Yun Z; Glazer PM
Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092693
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB/platelet-derived growth factor receptor-β axis.
Zhang D; Cui G; Sun C; Lei L; Lei L; Williamson RA; Wang Y; Zhang J; Chen P; Wang A; Fan R; Han S; Wang Y; Hu J
Biochem Biophys Res Commun; 2019 Apr; 512(2):360-366. PubMed ID: 30894277
[TBL] [Abstract] [Full Text] [Related]
[Next]
